Therapeutic Approaches for Wound-Associated Skin Diseases

Dear Colleagues,

We are pleased to invite you to contribute to our Special Issue “Therapeutic Approaches for Wound-Associated Skin Diseases” of Pharmaceutics.

The skin, posied at the interface between our body and the environment, is constantly exposed to pathogens, toxins, allergens and mechanical insults. Upon skin injury, a highly orchestrated program of wound healing, which consists of hemostasis, inflammation, proliferation and remodeling, is rapidly initiated. The dysregulation of any stage of the wound healing process may lead to the pathogenesis of several wound healing disorders, such as chronic wounds, hypertrophic scars and keloids, which affect more than 100 million patients world-wide without effective non-invasive treatment options. In addition, inflammatory skin diseases, such as psoriasis and vasculitis, are often triggered by injury to the skin. Therefore, the development of new therapeutic approaches for wound healing, skin regeneration, and inflammation resolution is urgently needed.

This Special Issue aims to highlight up-to-date knowledge and progress in therapeutic approaches for wound-related skin disorders, such as non-healing/inflammatory wounds (e.g., chronic wounds and diabetic wounds), fibrosis (e.g., hypertrophic scars and keloids), skin infections and wound-triggered inflammatory skin diseases (e.g., psoriasis and vasculitis).

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but not limited to) the following:

1. New drug development or biologics, delivery systems and target therapeutics for wound healing or wound-related diseases;
2. Establishment of a wound-related skin disorder model, demonstrating the effectiveness of this model for therapeutic study;
3. Novel detection methods or technologies for wound-related disease or wound healing;
4. Discovery of new mechanisms underlying an established drug or therapy for wound-related skin disorders.

We look forward to receiving your contributions.

Prof. Dr. Lingjuan Zhang
Prof. Dr. Jiang Wu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• wound healing
• skin regeneration
• chronic wounds
• skin fibrosis
• scarring
• inflammation
• drug delivery